Press Releases
Biospace Lab receives the 2008 European Imaging in Life Sciences Frost & Sullivan Product Line Strategy of the Year Award
London, UK & Paris, France – October 01, 2008 - The 2008 Frost & Sullivan European
Preclinical Small Animal Imaging Product Line Strategy of the Year Award is presented to
Biospace Lab for keeping abreast of market requirements with its strong product
portfolio. The company’s outstanding product line has allowed it to attract new
customers while satisfying existing ones, leading to increased market share.
“An in-depth understanding of, and ability to respond to, end user requirements supported by robust research and development efforts have yielded... Read the press release
Le communiqué de presse en français
“An in-depth understanding of, and ability to respond to, end user requirements supported by robust research and development efforts have yielded... Read the press release
Le communiqué de presse en français
New Software Platform and New Modules for Optical In-Vivo Imaging
August, 25th 2008: Biospace Lab Announces the Release of its New Software Platform “M3 VisionTM”
and the Development of New Modules for its Optical In-Vivo Imaging System
Paris (France), August 25th 2008 – Biospace Lab announces the commercialization of its new software platform for analysis and processing of images acquired with its preclinical imaging systems. M3 VisionTM is a multi-modality software solution combining accurate quantitation and kinetic analysis with precision export functionality. The initial version of M3 VisionTM, designed for analysis of optical images acquired from the Photon IMAGERTM System and available in standard and advanced modes, will be followed by another version enabling the integration and processing of... Read the press release
Le communiqué de presse en français
Paris (France), August 25th 2008 – Biospace Lab announces the commercialization of its new software platform for analysis and processing of images acquired with its preclinical imaging systems. M3 VisionTM is a multi-modality software solution combining accurate quantitation and kinetic analysis with precision export functionality. The initial version of M3 VisionTM, designed for analysis of optical images acquired from the Photon IMAGERTM System and available in standard and advanced modes, will be followed by another version enabling the integration and processing of... Read the press release
Le communiqué de presse en français
Collaboration agreement between Biospace Lab and Promega France
July, 15th 2008: Biospace Lab and Promega France sign a collaboration and co-promotion agreement
Biospace Lab and Promega announce today the companies have signed a collaboration and co-promotion agreement, which aims at encouraging the combined use of the imaging systems developped by Biospace Lab and the reagents and molecular probes marketed by Promega France. The combination of the Photon ImagerTM and Promega reagents help researchers perform accurate experiments for in vivo optical imaging in a large variety of fields like oncology, immunology or neurosciences.
"This agreement with Promega France, world leader of bioluminescence reagents, is of first importance to us" says Bruno Brisson, CEO of Biospace Lab. "The marketing of ready-to-use reagents with the Photon Imager brings a real added value for our clients and users". Read the press release (in French)
Biospace Lab and Promega announce today the companies have signed a collaboration and co-promotion agreement, which aims at encouraging the combined use of the imaging systems developped by Biospace Lab and the reagents and molecular probes marketed by Promega France. The combination of the Photon ImagerTM and Promega reagents help researchers perform accurate experiments for in vivo optical imaging in a large variety of fields like oncology, immunology or neurosciences.
"This agreement with Promega France, world leader of bioluminescence reagents, is of first importance to us" says Bruno Brisson, CEO of Biospace Lab. "The marketing of ready-to-use reagents with the Photon Imager brings a real added value for our clients and users". Read the press release (in French)
Networking: the European Research Area
March 2008: DiMI consortium and Biospace Lab are already living the idea of the “European Research Area"
In a changing world characterised by accelerated globalisation of research and technology, as well as by the emergence of new scientific and technological powers – namely China and India – the creation of the “European Research Area (ERA)” is now more than ever a cornerstone for the body of European knowledge. Under the direction of Bruno Brisson “Biospace lab” is already living the idea of “ERA”: These scientists are prepared to... Read more
In a changing world characterised by accelerated globalisation of research and technology, as well as by the emergence of new scientific and technological powers – namely China and India – the creation of the “European Research Area (ERA)” is now more than ever a cornerstone for the body of European knowledge. Under the direction of Bruno Brisson “Biospace lab” is already living the idea of “ERA”: These scientists are prepared to... Read more
Developments in in vivo optical imaging
December 2007: Biospace Lab announces its development plan
on its optical in vivo imaging system
Photon ImagerTM new features and add-ons to be launched in 2008
Biospace lab, a pre-clinical research company in molecular imaging, announced today a major development plans on its Photon ImagerTM, optical system for bioluminescence and fluorescence preclinical imaging. In addition to the In ActioTM module already commercialized for bioluminescence imaging on non-anesthetized animals, biospace lab is currently conducting internal R&D projects for developing new real-time and 3D bioluminescence / 3D fluorescence modules (patents pending technologies) that will lead to systems to be launched in second half of 2008. “Our philosophy for developing our flagship product in optic is to bring new features and possible add-ons to the system so that users will be able to... Read more
Photon ImagerTM new features and add-ons to be launched in 2008
Biospace lab, a pre-clinical research company in molecular imaging, announced today a major development plans on its Photon ImagerTM, optical system for bioluminescence and fluorescence preclinical imaging. In addition to the In ActioTM module already commercialized for bioluminescence imaging on non-anesthetized animals, biospace lab is currently conducting internal R&D projects for developing new real-time and 3D bioluminescence / 3D fluorescence modules (patents pending technologies) that will lead to systems to be launched in second half of 2008. “Our philosophy for developing our flagship product in optic is to bring new features and possible add-ons to the system so that users will be able to... Read more
Development of Biospace Lab
Nov 2007: Biospace Lab strengthens management team
and reinforces its presence in the USA
Biospace lab, a pre-clinical research company in molecular imaging, is pleased to announce today that Bruno Brisson has been appointed to the position of Chief Executive Officer. He initially was Director Sales & Marketing and General Manager. Marie Meynadier, previous President & Chief Executive Officer, will remain President of the Company. “Bruno’s new position strengthens a highly experienced management team which will focus on... Read more
Biospace lab, a pre-clinical research company in molecular imaging, is pleased to announce today that Bruno Brisson has been appointed to the position of Chief Executive Officer. He initially was Director Sales & Marketing and General Manager. Marie Meynadier, previous President & Chief Executive Officer, will remain President of the Company. “Bruno’s new position strengthens a highly experienced management team which will focus on... Read more
Molecular imaging on non-anesthetized animals
October 2007: Biospace Lab announces a technological breakthrough in molecular
imaging on non-anesthetized animals
In ActioTM optical modality opens new ways to conduct in vivo animal imaging studies.
Biospace Lab, molecular imaging company for preclinical research, is pleased to announce today the first scientific publication on studies using the unique In Actio™ module, add-on to its Photon Imager optical imaging system. The study, entitled “Non-Invasive In Vivo Imaging of Calcium Signaling in Mice”, was conducted...Read more
In ActioTM optical modality opens new ways to conduct in vivo animal imaging studies.
Biospace Lab, molecular imaging company for preclinical research, is pleased to announce today the first scientific publication on studies using the unique In Actio™ module, add-on to its Photon Imager optical imaging system. The study, entitled “Non-Invasive In Vivo Imaging of Calcium Signaling in Mice”, was conducted...Read more